摘要
外用制剂是治疗特应性皮炎的主要手段, 但目前国内对外用制剂的应用和患者指导尚存在一定的不足。中国中西医结合学会皮肤性病专业委员会环境与职业性皮肤病学组、中华医学会皮肤性病学分会儿童学组、中国老年保健医学研究会皮肤科分会的部分专家以国内外相关指南、共识和大量临床文献为基础, 结合专家临床经验, 制定特应性皮炎外用制剂的应用和患者指导共识, 旨在规范特应性皮炎外用制剂的应用, 提高疗效和安全性, 减少和预防复发。
Topical agents are main treatments of atopic dermatitis,and there are still many insufficiencies in the application of topical agents and patient education in China.Based on recent Chinese and international relevant guidelines,consensuses and literature,and combined with clinical experience from experts,some experts from Environmental and Occupational Skin Disease Research Group of Committee on Dermatology of Chinese Association of Integrative Medicine,Group on Children of Chinese Society of Dermatology,Committee on Dermatology of Chinese Association of Geriatric Research developed this consensus on the application of topical agents and patient education for atopic dermatitis,aiming to standardize the application of topical agents for atopic dermatitis,improve efficacy and safety,and reduce disease recurrence.
出处
《中华皮肤科杂志》
CAS
CSCD
北大核心
2022年第4期281-288,共8页
Chinese Journal of Dermatology
关键词
皮炎
特应性
外用药
病人教育
湿润剂
糖皮质激素类
钙调磷酸酶抑制剂
磷酸二酯酶4抑制剂
共识
Dermatitis,atopic
External application drugs
Patient education
Wetting agents
Glucocorticoids
Calcineurin inhibitors
Phosphodiesterase 4 inhibitors
Consensus
